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PIA has previously been analysed using a series of inbred, MHC congenic and recombinant inbred strains^[@CR6]^. It was found that the DA strain is highly susceptible to PIA, whereas the E3 strain is resistant, and that the major histocompatibility complex (MHC) region (*Pia1*) influences the chronicity of the disease. Moreover, analysis of recombinant inbred strains made from DA and E3 showed that the disease is polygenic. To map genes involved in PIA, we made F1 and F2 crosses between the E3 and the DA strains ([Table 1](#Tab1){ref-type="table"}). F1 rats developed chronic PIA, indicating dominant genes, but with delayed onset (*P*\<0.0001) and reduced severity (*P*\<0.0001) compared with the DA parental rats, suggesting incomplete penetrance due to the presence of recessive and/or additive genes. Consistent with earlier reports^[@CR6]^, females were more susceptible than males. In the F2 population, the disease course was more variable and examples of the different disease patterns are shown ([Fig. 1](#Fig1){ref-type="fig"}). All 153 (E3×DA) F2 rats were subjected to a near-complete genome screen using a set of 330 informative microsatellites. The identified QTLs are summarized ([Table 2](#Tab2){ref-type="table"}), and log-likelihood plots ([Fig. 2](#Fig2){ref-type="fig"}) as well as chromosomal locations ([Fig. 3](#Fig3){ref-type="fig"}) are shown.Table 1PIA susceptibility in parental, F1 and F2 animalsFigure 1Examples of disease courses in individual (E3×DA) F2 rats with acute and chronic development of arthritis.Clinical scoring was carried out as previously described^[@CR10]^.Table 2Chromosome regions showing evidence of linkage to arthritis-associated traitsFigure 2Lod score plots for chromosomes indicating identified QTLs.A solid horizontal line showing the threshold for significant linkage in a fixed mode of inheritance with correction for mutiple testing is indicated (at lod score 3.9).Figure 3Linkage map of chromosomes with identified QTLs and with the used markers indicated.The largest intermarker distance on each chomosome is indicated. The chromosomal length and intermarker linkage distances are proportional to the graphic length. The black vertical bars indicate regions of the chromosomes where the lod score exceeds 3.9 (thick bars) and 2.9 (thin bars). Earlier suggested loci in other crosses involving autoimmune diseases are indicated with grey bars. These include the *Iddm1* locus (rat diabetes model^[@CR8],[@CR9]^), the *Oia2* locus (oil-induced arthritis model^[@CR17]^) and the *Cia3* locus (collagen-induced arthritis model^[@CR7]^\>).

Arthritis usually developed with a sudden onset in a peripheral joint, and rapidly progressed over the next few days. As in RA, the distribution of affected joints was predominantly symmetric (85% of the affected joints were symmetric at day 35). A locus on chromosome 6 (*Pia3*) was linked to the day of arthritis onset, but an indication of linkage was also found on chromosome 4; this linkage became significant (*Pia2*) when only females were analysed, despite the decrease in power by the reduced number of rats. This indicates that the gene is dependent on a female context. Both loci appear to control a delayed disease onset in a DA recessive mode ([Fig. 4](#Fig4){ref-type="fig"}); that is, they contain disease susceptibility genes derived from E3. None of the loci controlling arthritis onset influenced further progression of the disease ([Fig. 4](#Fig4){ref-type="fig"}).Figure 4Mean day of onset of arthritis (***a***) and mean inflammation score 120 d after pristane injection (***b***), with the linked markers identifying QTLs in the (E3×DA) F2 cross.Bars indicate s.e.m.

A major locus (*Pia4*) was found on chromosome 12 that controls arthritis severity during the early period between day 20 and day 45 in the (E3×DA) F2 cross ([Table 2](#Tab2){ref-type="table"}, [Fig. 2*c*](#Fig2){ref-type="fig"}). DA alleles promoted disease in an additive fashion (data not shown). The strongest linkage was seen with the number of affected paws between day 28 and 35, during a period in which joint erosion was most extensive. As a consequence, high serum levels of cartilage oligomeric matrix protein (COMP) were linked to the same region, during the same period, with an identical inheritance pattern at day 35 ([Fig. 2](#Fig2){ref-type="fig"}). Thus, COMP and number of affected paws on day 35 showed a positive correlation (*R*~*s*~=0.66, *P*\<1×10^--7^). We also observed possible, but not significant, influence on arthritis onset and chronicity by *Pia4* ([Fig. 4](#Fig4){ref-type="fig"}).

To identify loci controlling chronicity, we used the number of affected paws at late stages (after 8 weeks) and inflammation scores of joint histopathology sections at a very late stage of arthritis (approximately day 120). These phenotypes were positively correlated (*R*~*s*~=0.72, *P*\<1×10^--7^), but may reflect different aspects because histopathology was carried out on the most affected paw at the end of the experiment, whereas the number of affected paws takes into account all paws during a longer period. A locus (*Pia6*) on chromosome 14 was significantly linked to the number of affected paws from day 83 (lod score 4.2), and lod scores increased as the disease progressed with time. When males and females were analysed separately, an additional locus on chromosome 4 (*Pia5)* associated with inflammation scores was found in males. Loci linked to chronicity (*Pia5* and *Pia6*; [Fig. 2*f,g,h*](#Fig2){ref-type="fig"}) were not associated with onset or severity of arthritis ([Fig. 4](#Fig4){ref-type="fig"}). Our analysis showed that the DA strain has a recessive disease-promoting allele at *Pia6* and an additive allele at *Pia6* ([Fig. 4](#Fig4){ref-type="fig"}). One of the loci controlling chronicity, *Pia5*, is located in the vicinity of the previously described *Cia3* locus, which controls collagen-induced arthritis^[@CR7]^, and the *Lyp/Iddm1* locus, which is associated with lymphopenia, diabetes and thyroiditis in the BB rat^[@CR8],[@CR9]^ ([Fig. 3](#Fig3){ref-type="fig"}). This may indicate the presence of a common susceptibility gene for several autoimmune diseases. The MHC region has been found to control the development of chronic arthritis in PIA using LEW congenic strains^[@CR6]^, and the designation *Pia1* is therefore reserved for this locus. *Pia1* was, however, not found in the present cross, possibly due to the fact that none of the parental strains had the most susceptible haplotype (RT1^f^).

Our results show that arthritis chronicity is controlled by genes other than those associated with onset and early events of the disease. Future analysis of subphenotypes linked to QTLs and identification of the underlying genes will cast new light on the pathogenesis of PIA. An understanding of the role of these genes in the disease process of the experimental model should make possible the identification of critical events in the pathogenesis of RA.

Methods {#Sec2}
=======

Animals. {#Sec3}
--------

Pathogen-free rats originating from ZFV (Zentralinstitut für Versuchstierzucht) were kept in animal facilities in a climate-controlled environment with 12 h light/dark cycles, housed in polystyrene cages containing wood shavings and fed standard rodent chow and water *ad libitum*. The rats were found to be free of common pathogens including Sendai virus, Hantavirus, coronavirus, reovirus, cytomegalovirus and mycoplasma pulmonis.

Induction and evaluation of arthritis. {#Sec4}
--------------------------------------

Arthritis was induced by an intradermal injection at the base of the tail with pristane (150 μl; 2,6,10,14-tetramethylpentadecane; Aldrich). Arthritis development was monitored by a macroscopic scoring system for the four limbs ranging 0-4 (1, swelling and redness of one joint; 2, two joints involved; 3, more than two joints involved; 4, severe arthritis in the entire paw)^[@CR10]^. The scores of the four paws were added, yielding a maximum total score of 16 for each rat. The rats were observed 1-3 times a week during the experiment. (E3×DA) F2 rats were killed 120 d after pristane injection. The most severely affected paw from each rat was decalcified and subjected to histopathologic analyses and then evaluated by microscopic scoring (0-3) of active inflammation, as described^[@CR10]^. Blood was obtained by cutting the tip of the tail. The rats were bled on days 6, 14, 35, 49 and 100 after pristane injection. The serum levels of cartilage oligomeric matrix protein (COMP) were measured as described^[@CR11]^.

Arthritis phenotypes. {#Sec5}
---------------------

The following phenotypes were determined: \'day of onset\', first day a clinical score of 1 or higher was obtained; \'clinical score\', clinical score (scores 0-16) of each rat at the indicated day after pristane injection; \'COMP\', serum level of COMP at the indicated day (in titre values); \'no. of affected paws\', number of paws with arthritis (scores 0-4) at the indicated day; \'inflammation score\', microscopic score (0-3) of active inflammation in sections of joints obtained 120 d after pristane injection. The phenotypes described by clinical scores, number of affected paws and COMP before d 56 gave essentially the same significance values after immunization and were regarded as reflecting severity and early joint erosion. The inflammation scores at d 120 and clinical scores and number of affected paws at or after d 56 were also correlated and are regarded as reflecting chronicity. Correlations between phenotypes were analysed using the Spearman rank correlation test.

Genotyping and linkage analysis. {#Sec6}
--------------------------------

Rat microsatellite markers defined as *DxMity* and *DxMghy* were purchased (Research Genetics). Microsatellite markers defined as *DxWoxy* were obtained from the Wellcome Institute for Human Genetics. All markers were assayed by PCR as follows: genomic DNA (20 ng) was amplified in a final volume (10 μl) containing primer (0.5 μM each), dNTPs (200 μM), MgCl~2~ (1.5 mM), Tris-HCl (20 mM, pH 9.0) and *Taq* DNA polymerase (1 U). One primer was labelled with ^32^P-λATP (3000 Ci/mmol; Dupont/NEN) using T4 polynucleotide kinase (Amersham). Amplification conditions were as follows: 94 °C for 3 min, followed by 25 cycles of 94 °C for 15 s, 55 °C for 2 min, 72 °C for 3 min and final extension at 72 °C for 7 min. Reactions were performed using an MJR Thermal Cycler (PTC 225, MJ Research). The PCR products were size-fractionated on 6% (Bio-Rad, FMC) polyacrylamide gels in 1×TBE. Gels were exposed on autoradiographic film (Amersham Hyperfilm MP) at -70 °C for 12-36 h.

Linkage analysis was performed using MAPMAKER (refs [@CR12],[@CR13],[@CR14],[@CR15]). Genetic linkage maps were initially constructed using genotype data from 92 F2 progeny. These were selected from the phenotypic extremes. Although improper location of some of the markers used caused difficulty, these markers could be positioned with high probability using additional F2 offspring from other crosses based on the DA and E3 strains. Thus, an improved genetic map was constructed (http://www.cmb.lu.se/contrib/avd-0/e-avd-0.html; N.N. *et al.*, manuscript submitted). Linkage analysis was performed using all determined phenotypic scores (that is, including zero values) and regions for which lod scores exceeded 1.5 were typed for the remaining animals, including more markers where needed.
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